AEZ.AX - Stock quotes
Stock Quotes Home
Live Stock Quotes - Symbol Lookup
Enter Symbol


Chart for ticker : 0.004
Ticker : AEZ.AX
Last Trade : 0.004
Last Trade At : 2/9/2012 10:55pm
Change : +0.001
Opened At : 0.004
Day Range : 0.004 - 0.004
Volume : 450000
More Details: http://finance.yahoo.com/q?s=AEZ.AX

Data delayed by 15 minutes

Detailed Chart for AEZ.AX and Technical Analysis

News Headlines for AEZ.AX
IMPORTANT: Bing News RSS feed has moved!
table bgColorffffbb border1pxtdGo to thenbspa hrefhttpapi.bing.comrss.aspxSourceNewsampMarketen-USampVersion2.0 ampQueryAEZ.AXnew RSS pageanbspand renew your subscription.tdtable
Aeterna Zentaris to Present at BIO CEO Investor and RBC Capital Markets Global Healthcare Conferences in New York
QUBEC CITY Feb. 7 2012 CNW Telbec - Aeterna Zentaris Inc. NASDAQ AEZS TSX theCompany today announced that Paul Blake MD the Companys Senior Vice President and Chief of Medical Affairs will be presenting a Company overview at the ...
Positive updated results from Aeterna Zentaris' AEZS-108 Phase 1 trial on CRPC
Aeterna Zentaris Inc. NASDAQ AEZS TSX the Company today reported positive updated results for the Phase 1 portion of its ongoing Phase 12 study in castration- and taxane-resistant prostate cancer CRPC with AEZS-108 zoptarelin ...
Report: A's extend Beane's contract through 2019
Oakland Athletics owner Lew Wolff has agreed to extend the contracts of general manager Billy Beane and team president Michael Crowley through the 2019 season. The deals are in the process of being finalized Wolff confirmed to the Associated ...
Aeterna Zentaris - An Up Close And Personal Look
One of the companies pursuing this innovative approach of personalized medicine is Canadian drugmaker Aeterna Zentaris Inc. AEZS .TO. For readers who are new to Aeterna heres a brief overview of its product pipeline and what to expect ...
Aeterna Zentaris Announces "At-the-Market" Issuance Program
QUEBEC CITY Jan. 23 2012 PRNewswire - Aeterna Zentaris Inc. NASDAQAEZS TSX the Company a late-stage drug development company specialized in oncology and endocrine therapy announced today that pursuant to its existing At-the-Market ...
Perifosine Results
Average quality rating by the Stockhouse community. Although we are all optomistic of a successful stage 3 trial I believe we have a lot of insurance or backup support in the other drugs is developing. So at worst case I dont believe the stock would ...
Earthquake strikes off coast of Philippines
A 6.8-magnitude earthquake struck Monday off the third-largest island in the Philippines killing at least six people and prompting the country to issue a tsunami alert for the coastlines near the epicenter. The quake struck about 1149 a.m. 10 ...
Wade to miss 3rd straight game
Heat guard Dwyane Wade will miss his 3rd consecutive game Saturday when the Heat host the Philadelphia 76ers. He is still nursing a sprained ankle. Wade was able to practice on Friday but the Heat are being cautious with the all-star guard ...
Aeterna Zentaris: Updated Interim Phase 1 Trial Results for AEZS-108 in Prostate Cancer To Be Presented at Upcoming ASCO GCS Meeting in San Francisco
AEZS-108 zoptarelin doxorubicin represents a new targeting concept in oncology using a hybrid molecule composed of a synthetic peptide carrier and a well-known chemotherapy agent doxorubicin. AEZS-108 is the first intravenous drug in a clinical study ...

Live Stock Quotes
Enter Symbol

Home | About |  Directory |  Contact |  News |  Newsletter | www.finance.com.au